CD274 and renal cell carcinoma: These distinctions in gene signatures associated with immunosuppressive cell types could be relevant to the choice of immunotherapy in RCC because similar immunosuppressive signatures have been shown to be associated with poor response to anti-PD-(L)1 therapy.